Exogenous insulin supplementation is the conventional approach for T1DM treatment; however, miRNAs present in immune cell-derived extracellular vesicles can promote islet β cell apoptosis and serves as biomarkers for T1DM prevention and treatment. The gene discussed is INS; the disease is type 1 diabetes mellitus.